Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea.
about
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsMechanisms and therapeutic effectiveness of lactobacilliNovel approaches to treating Clostridium difficile-associated colitis.The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent.Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewClinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile Infection.Therapies on the horizon for Clostridium difficile infections.Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis.The Potential of Lactobacillus casei and Entercoccus faecium Combination as a Preventive Probiotic Against Entamoeba.Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis.Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.The Group: History and Health Related Applications
P2860
Q26752760-61806B6F-C7C6-4C41-BD29-4AD0D99E0FF0Q27012999-030FD92D-F580-47BF-9384-296DAD398255Q35862915-F36AF879-C1A7-4966-A6E1-327F402E7E5AQ35880704-C882D223-3F72-47EE-9E16-5B0159745951Q36683562-12C4DFB1-BF0F-48F6-8FA8-331A77234C4CQ38747097-BF31A17C-B52E-42B1-92F4-10768695C068Q38757930-23173779-93B0-4719-804E-AF8514C1B5D9Q39429041-5DE08986-D69B-4058-8B80-0265A39EAC24Q40515251-080B2899-6022-4583-8081-62202F88B566Q52670890-8B459E37-5353-4CF1-86C4-118635578D4EQ54226920-EB87749E-D7C5-45DC-983A-C3746661A2F6Q55023884-51AAD850-16EF-4D93-B5A8-8FB26EC9B918Q57300497-760CDA61-DB44-4C11-8C3B-4DAF98E05BA3
P2860
Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Commercially available probiot ...... ntibiotic-associated diarrhea.
@ast
Commercially available probiot ...... ntibiotic-associated diarrhea.
@en
Commercially available probiot ...... ntibiotic-associated diarrhea.
@nl
type
label
Commercially available probiot ...... ntibiotic-associated diarrhea.
@ast
Commercially available probiot ...... ntibiotic-associated diarrhea.
@en
Commercially available probiot ...... ntibiotic-associated diarrhea.
@nl
prefLabel
Commercially available probiot ...... ntibiotic-associated diarrhea.
@ast
Commercially available probiot ...... ntibiotic-associated diarrhea.
@en
Commercially available probiot ...... ntibiotic-associated diarrhea.
@nl
P2093
P2860
P1476
Commercially available probiot ...... ntibiotic-associated diarrhea.
@en
P2093
Christoph G Dietrich
Manuela Alavi
Tanja Kottmann
P2860
P304
15837-15844
P356
10.3748/WJG.V20.I42.15837
P407
P577
2014-11-01T00:00:00Z